Haemonetics Corp. | Ownership

Companies that own Haemonetics Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
BlackRock Fund Advisors
5,550,542
10.74%
-958,592
0.03%
06/30/2018
The Vanguard Group, Inc.
5,400,549
10.45%
-149,582
0.02%
06/30/2018
Wellington Management Co. LLP
2,115,273
4.09%
-996,455
0.04%
06/30/2018
Renaissance Technologies LLC
1,969,700
3.81%
650,200
0.23%
06/30/2018
SSgA Funds Management, Inc.
1,813,427
3.51%
410,039
0.02%
06/30/2018
Jackson Square Partners LLC
1,769,300
3.42%
1,769,300
0.73%
06/30/2018
Capital Research & Management Co. (Global Investors)
1,624,000
3.14%
400,000
0.03%
06/30/2018
Neuberger Berman Investment Advisers LLC
1,515,638
2.93%
-223,295
0.18%
06/30/2018
Dimensional Fund Advisors LP
1,440,600
2.79%
-111,369
0.04%
06/30/2018
Franklin Advisers, Inc.
1,001,925
1.94%
1,925
0.07%
06/30/2018

About Haemonetics

View Profile
Address
400 Wood Road
Braintree Massachusetts 02184
United States
Employees -
Website http://www.haemonetics.com
Updated 07/08/2019
Haemonetics Corp. is a healthcare company, which engages in the development and distribution of hematology products and solutions. It operates through the following geographical segments: Japan, EMEA (Europe, the Middle East, and Africa), North America Plasma, and All Other. Its products include surgical and diagnostic devices, blood and plasma center devices, blood center software, hospital software, and plasma center software.